Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Heparin Market Size study, by Type (Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin) by Route of Administration (Intravenous, Subcutaneous) by Application (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Others) by End-use (Outpatient, Inpatient) by Source (Porcine, Bovine, Others) and Regional Forecasts 2022-2028

  • BIZ4983522
  • 200 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Heparin Market is valued approximately USD 7.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 2.4% over the forecast period 2022-2028. Heparin, commonly known as unfractionated heparin, is a glycosaminoglycan that occurs naturally. Heparins are anticoagulants since they rely on the activity of antithrombin. The market is expected to be driven by the rising prevalence of illnesses such as renal impairment, coronary artery disease, and venous thromboembolism. According to the CDC, in 2022, around 900,000 people in the United States may be impacted by venous thromboembolism, which may result in the death of 10% - 30% of persons within one month of diagnosis. Anticoagulant demand is expected to drive the entire industry. Furthermore, growing health-care expenditures and government-led efforts are among the important drivers expected to fuel market expansion. One of the primary reasons driving the overall market is the rising prevalence of chronic illnesses such as cardiovascular disorders and renal diseases. Diabetes prevalence over 30 years was 13.8 percent in 2020, according to the Korea Biomedical, . Diabetes patients are more likely to experience blood coagulation, which can lead to heart disease and renal issues. Heparin's application in the treatment of such illnesses is expected to fuel market expansion. The COVID-19 epidemic has greatly raised the market between 2020 and 2021. According to the JAMA Journal in 2021, aberrant blood clots are widespread in COVID-19 patients due to clot-promoting autoantibodies, which cause deep vein thrombosis and pulmonary embolisms, opening the door for heparin. According to a 2021 article published in the Journal of the American Heart Association (JAHA), early-stage anticoagulation treatment with low-molecular-weight heparin might better prevent COVID19-associated coagulopathy and endotheliopathy, leading to a better prognosis in a patient. All of the variables mentioned above are projected to contribute to market expansion. However, the side effects of heparin hinder market growth throughout the projection period of 2022-2028.

The key regions considered for the Global Heparin Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America led the market and had the highest revenue share in 2021. This is because cardiovascular problems and injuries are on the rise. Furthermore, rising healthcare expenditure levels and increased patient awareness in this region might be related to the region's high proportion. The market in Asia Pacific is expected to develop at the quickest rate during the forecast period. Some of the key drivers driving expansion are an ageing population, a big population with chronic disease, and expanding economies. In addition, Asia Pacific is the main source of crude heparin and its API. This benefits local businesses like Pharmax Lifesciences. Local firms are developing low-cost generic versions of patent-expired pharmaceuticals.

Major market player included in this report are:

Pfizer Inc.

LEO Pharma A/S

Dr. Reddy’s Laboratories Ltd.

GlaxoSmithKline plc

Sanofi

Aspen Holdings

Fresenius SE & Co. KGaA

B. Braun Medical, Inc.

Sandoz (Novartis AG)

Baxter International Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Low Molecular Weight Heparin

Ultra-low Molecular Weight Heparin

Unfractionated Heparin

By Source:

Porcine

Bovine

Others

By Route of Administration:

Intravenous

Subcutaneous

By Application:

Venous Thromboembolism

Atrial Fibrillation

Renal Impairment

Coronary Artery Disease

Others

By End-use:

Outpatient

Inpatient

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Heparin Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. Heparin Market, by Region, 2020-2028 (USD Billion)

1.2.2. Heparin Market, by Type, 2020-2028 (USD Billion)

1.2.3. Heparin Market, by Source, 2020-2028 (USD Billion)

1.2.4. Heparin Market, by Route of Administration, 2020-2028 (USD Billion)

1.2.5. Heparin Market, by Application, 2020-2028 (USD Billion)

1.2.6. Heparin Market, by End-Use, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Heparin Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Heparin Market Dynamics

3.1. Heparin Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Increasing incidence of diabetes

3.1.1.2. Growing geriatric population

3.1.2. Market Challenges

3.1.2.1. High cost of Heparin

3.1.3. Market Opportunities

3.1.3.1. Advancements in formulation

Chapter 4. Global Heparin Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Heparin Market, by Type

6.1. Market Snapshot

6.2. Global Heparin Market by Type, Performance - Potential Analysis

6.3. Global Heparin Market Estimates & Forecasts by Type 2018-2028 (USD Billion)

6.4. Heparin Market, Sub Segment Analysis

6.4.1. Low Molecular Weight Heparin

6.4.2. Ultra-low Molecular Weight Heparin

6.4.3. Unfractionated Heparin

Chapter 7. Global Heparin Market, by Source

7.1. Market Snapshot

7.2. Global Heparin Market by Source, Performance - Potential Analysis

7.3. Global Heparin Market Estimates & Forecasts by Source 2018-2028 (USD Billion)

7.4. Heparin Market, Sub Segment Analysis

7.4.1. Porcine

7.4.2. Bovine

7.4.3. Others

Chapter 8. Global Heparin Market, by Route of Administration

8.1. Market Snapshot

8.2. Global Heparin Market by Route of Administration, Performance - Potential Analysis

8.3. Global Heparin Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Billion)

8.4. Heparin Market, Sub Segment Analysis

8.4.1. Intravenous

8.4.2. Subcutaneous

Chapter 9. Global Heparin Market, by Application

9.1. Market Snapshot

9.2. Global Heparin Market by Application, Performance - Potential Analysis

9.3. Global Heparin Market Estimates & Forecasts by Application 2018-2028 (USD Billion)

9.4. Heparin Market, Sub Segment Analysis

9.4.1. Venous Thromboembolism

9.4.2. Atrial Fibrillation

9.4.3. Renal Impairment

9.4.4. Coronary Artery Disease

9.4.5. Others

Chapter 10. Global Heparin Market, by End-Use

10.1. Market Snapshot

10.2. Global Heparin Market by End-Use, Performance - Potential Analysis

10.3. Global Heparin Market Estimates & Forecasts by End-Use 2018-2028 (USD Billion)

10.4. Heparin Market, Sub Segment Analysis

10.4.1. Outpatient

10.4.2. Inpatient

Chapter 11. Global Heparin Market, Regional Analysis

11.1. Heparin Market, Regional Market Snapshot

11.2. North America Heparin Market

11.2.1. U.S. Heparin Market

11.2.1.1. Type breakdown estimates & forecasts, 2018-2028

11.2.1.2. Source breakdown estimates & forecasts, 2018-2028

11.2.1.3. Route of Administration breakdown estimates & forecasts, 2018-2028

11.2.1.4. Application breakdown estimates & forecasts, 2018-2028

11.2.1.5. End-Use breakdown estimates & forecasts, 2018-2028

11.2.2. Canada Heparin Market

11.3. Europe Heparin Market Snapshot

11.3.1. U.K. Heparin Market

11.3.2. Germany Heparin Market

11.3.3. France Heparin Market

11.3.4. Spain Heparin Market

11.3.5. Italy Heparin Market

11.3.6. Rest of Europe Heparin Market

11.4. Asia-Pacific Heparin Market Snapshot

11.4.1. China Heparin Market

11.4.2. India Heparin Market

11.4.3. Japan Heparin Market

11.4.4. Australia Heparin Market

11.4.5. South Korea Heparin Market

11.4.6. Rest of Asia Pacific Heparin Market

11.5. Latin America Heparin Market Snapshot

11.5.1. Brazil Heparin Market

11.5.2. Mexico Heparin Market

11.6. Rest of The World Heparin Market

Chapter 12. Competitive Intelligence

12.1. Top Market Strategies

12.2. Company Profiles

12.2.1. Pfizer Inc

12.2.1.1. Key Information

12.2.1.2. Overview

12.2.1.3. Financial (Subject to Data Availability)

12.2.1.4. Type Summary

12.2.1.5. Recent Developments

12.2.2. LEO Pharma A/S

12.2.3. Dr. Reddy’s Laboratories Ltd.

12.2.4. GlaxoSmithKline plc

12.2.5. Sanofi

12.2.6. Aspen Holdings

12.2.7. Fresenius SE & Co. KGaA

12.2.8. B. Braun Medical, Inc.

12.2.9. Sandoz (Novartis AG)

12.2.10. Baxter International

Chapter 13. Research Process

13.1. Research Process

13.1.1. Data Mining

13.1.2. Analysis

13.1.3. Market Estimation

13.1.4. Validation

13.1.5. Publishing

13.2. Research Attributes

13.3. Research Assumption

List of Tables

TABLE 1. Global Heparin Market, report scope

TABLE 2. Global Heparin Market estimates & forecasts by Region 2018-2028 (USD Billion)

TABLE 3. Global Heparin Market estimates & forecasts by Type 2018-2028 (USD Billion)

TABLE 4. Global Heparin Market estimates & forecasts by Source 2018-2028 (USD Billion)

TABLE 5. Global Heparin Market estimates & forecasts by Route of Administration 2018-2028 (USD Billion)

TABLE 6. Global Heparin Market estimates & forecasts by Application 2018-2028 (USD Billion)

TABLE 7. Global Heparin Market estimates & forecasts by End-Use 2018-2028 (USD Billion)

TABLE 8. Global Heparin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 9. Global Heparin Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 10. Global Heparin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 11. Global Heparin Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 12. Global Heparin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 13. Global Heparin Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 14. Global Heparin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 15. Global Heparin Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 16. Global Heparin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 17. Global Heparin Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 18. U.S. Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 19. U.S. Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 20. U.S. Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 21. Canada Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 22. Canada Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 23. Canada Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 24. UK Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 25. UK Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 26. UK Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 27. Germany Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 28. Germany Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 29. Germany Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 30. RoE Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 31. RoE Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 32. RoE Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 33. China Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 34. China Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 35. China Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 36. India Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 37. India Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 38. India Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 39. Japan Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 40. Japan Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 41. Japan Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 42. RoAPAC Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 43. RoAPAC Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 44. RoAPAC Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 45. Brazil Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 46. Brazil Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 47. Brazil Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 48. Mexico Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 49. Mexico Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 50. Mexico Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 51. RoLA Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 52. RoLA Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 53. RoLA Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 54. Row Heparin Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 55. Row Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 56. Row Heparin Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 57. List of secondary sources, used in the study of global Heparin Market

TABLE 58. List of primary sources, used in the study of global Heparin Market

TABLE 59. Years considered for the study

TABLE 60. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research